estimating transfusion-related medical costs & time burden in patients with mf in simplify-1
Published 8 months ago • 42 plays • Length 3:17Download video MP4
Download video MP3
Similar videos
-
1:16
insights into an oncology simulation model being used to evaluate treatment regimens in hl
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
1:44
patient reported outcomes in myeloid malignancies
-
1:57
combining molecular and clinical data to predict survival & transformation risk in patients with mds
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
6:28
outcomes following first-line therapy in routine clinical practice in alcl
-
8:40
lenalidomide, mutations & mds outcomes
-
1:11
making clinical decisions with patients
-
0:55
a pooled analysis to determine the optimal ki-67 index cut-off point for predicting outcomes in mcl
-
1:59
outcomes from myeloma xi - what do the results tell us?
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:47
using artificial intelligence to estimate overall mortality and non-relapse mortality after allosct
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:52
long-term evaluation of luspatercept in esa-intolerant/refractory lr-mds: medalist follow-up study
-
2:01
elm-2 trial: using ctdna and mrd to measure odronextamab outcomes in dlbcl and fl
-
4:12
opportunities to improve car-t outcomes
-
3:14
using machine learning to identify trajectories of hematotoxicity following car t-cell therapy